Over recent years, we have investigated the impact of progestins on breast cancer, indicating a role of PGRMC1 in the signaling cascade after binding of progestins to hormone receptors [18–20, 35–38, 44–47, 52]. Here, PGRMC1 is linked to breast cancer.